Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 685,924 shares at $85.40 ($59.0M) on 2021-04-28, disclosed to the SEC on 2021-04-28.
Open-market sale of $59.0M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.93 | 806 | $68K | 0.1% |
| 2 | $84.93 | 806 | $68K | 0.1% |
| 3 | $85.39 | 79,714 | $6.8M | 11.5% |
| 4 | $85.39 | 79,714 | $6.8M | 11.5% |
| 5 | $86.41 | 68,836 | $5.9M | 10.1% |
| 6 | $86.41 | 68,836 |
| $5.9M |
| 10.1% |
| 7 | $87.08 | 61,680 | $5.4M | 9.1% |
| 8 | $87.08 | 61,680 | $5.4M | 9.1% |
| 9 | $85.40 | 102,186 | $8.7M | 14.8% |
| 10 | $85.40 | 102,186 | $8.7M | 14.8% |
| 11 | $86.12 | 29,740 | $2.6M | 4.3% |
| 12 | $86.12 | 29,740 | $2.6M | 4.3% |
| Total | $85.96 avg | 685,924 | $59.0M | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |